We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Science (New York, N.Y.) | Aug 17, 1990

Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.

Pubmed ID: 2167514 RIS Download

Mesh terms: Animals | Apolipoprotein C-III | Apolipoproteins C | Chylomicrons | Cloning, Molecular | DNA Restriction Enzymes | DNA, Recombinant | Gene Expression | Humans | Hypertriglyceridemia | Lipoproteins, VLDL | Mice | Mice, Inbred C57BL | Mice, Inbred CBA | Mice, Transgenic | Nucleic Acid Hybridization | RNA, Messenger | Triglycerides

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL 36461
  • Agency: NHLBI NIH HHS, Id: HL33435
  • Agency: NHLBI NIH HHS, Id: HL33714

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.